Aurobindo Pharma's US subsidiary has partnered with a global pharmaceutical company to develop and sell respiratory products. The collaboration involves a shared cost of up to $90 million over three to five years, with both companies sharing marketing rights while the unnamed partner handles manufacturing.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.